Ignite Creation Date:
2024-10-26 @ 3:38 PM
Last Modification Date:
2024-10-26 @ 3:38 PM
Study NCT ID:
NCT06567353
Status:
NOT_YET_RECRUITING
Last Update Posted:
None
First Post:
2024-08-20
Brief Title:
A Multi-mode Thermophysical Immunotherapy Study for Breast Cancer Liver Metastases
Sponsor:
None
Organization:
None
Study Overview
Official Title:
A Multi-mode Thermophysical Immunotherapy Study for Breast Cancer Liver Metastases
Status:
NOT_YET_RECRUITING
Status Verified Date:
2024-05
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This is a single-center parallel-controlled clinical study designed to evaluate the safety efficacy and impact on systemic anti-tumor immunity of a multi-mode integrated ablation system for the treatment of breast cancer liver metastases
Detailed Description:
This is a single-center parallel-controlled clinical study The study plans to enroll 10 subjects with 5 in the multi-mode ablation group experimental group and 5 in the conventional radiofrequency ablation group control group The entire study includes a screening period treatment period and follow-up period By comparing multi-mode ablation with conventional radiofrequency ablation the study aims to observe the efficacy safety of the multi-mode ablation technique in subjects and its impact on the systemic anti-tumor immunity of subjects
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None